title: Caffeine and Parkinson's disease: are we getting our fix on risk-modifying gene-environment interactions?
authors.forename: G D
authors.initials: GD
authors.lastname: Mellick
authors.forename: O A
authors.initials: OA
authors.lastname: Ross
mesh_terms: D002110:Caffeine / Q000378:metabolism*; D019388:Cytochrome P-450 CYP1A2 / Q000235:genetics*; D005260:Female; D020022:Genetic Predisposition to Disease / Q000235:genetics*; D006801:Humans; D008297:Male; D018696:Neuroprotective Agents / Q000494:pharmacology*; D010300:Parkinson Disease / Q000235:genetics*; D043705:Receptor, Adenosine A2A / Q000235:genetics*
chemical_list: D018696:Neuroprotective Agents; D043705:Receptor, Adenosine A2A; D002110:Caffeine; C504573:CYP1A2 protein, human; D019388:Cytochrome P-450 CYP1A2